Luteinizing hormone Completed Phase 3 Trials for Hypogonadism Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01084265A Study Using Recombinant Human Luteinizing Hormone (r-hLH, LuverisĀ®) in the Treatment of Chinese Women With Hypogonadotropic Hypogonadism